Cargando…
Nirmatrelvir/ritonavir as a possible treatment for Long-COVID
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Quimioterapia
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586732/ https://www.ncbi.nlm.nih.gov/pubmed/37357766 http://dx.doi.org/10.37201/req/028.2023 |
| _version_ | 1785123206427836416 |
|---|---|
| author | Catalán, Ignacio Pérez Buj, Adriana Gascón Muñoz, Sergio García Alfaro, Iris Gómez Martí, Celia Roig García, Miguel Torres Valero, Roberto Reig Piqueres, Raúl Ferrando Campos, Lidón Mateu Rincón, José Manuel Ramos Blasco, Jorge Usó |
| author_facet | Catalán, Ignacio Pérez Buj, Adriana Gascón Muñoz, Sergio García Alfaro, Iris Gómez Martí, Celia Roig García, Miguel Torres Valero, Roberto Reig Piqueres, Raúl Ferrando Campos, Lidón Mateu Rincón, José Manuel Ramos Blasco, Jorge Usó |
| author_sort | Catalán, Ignacio Pérez |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10586732 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Sociedad Española de Quimioterapia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105867322023-10-20 Nirmatrelvir/ritonavir as a possible treatment for Long-COVID Catalán, Ignacio Pérez Buj, Adriana Gascón Muñoz, Sergio García Alfaro, Iris Gómez Martí, Celia Roig García, Miguel Torres Valero, Roberto Reig Piqueres, Raúl Ferrando Campos, Lidón Mateu Rincón, José Manuel Ramos Blasco, Jorge Usó Rev Esp Quimioter Letter to the Editor Sociedad Española de Quimioterapia 2023-06-27 2023 /pmc/articles/PMC10586732/ /pubmed/37357766 http://dx.doi.org/10.37201/req/028.2023 Text en © The Author 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/). |
| spellingShingle | Letter to the Editor Catalán, Ignacio Pérez Buj, Adriana Gascón Muñoz, Sergio García Alfaro, Iris Gómez Martí, Celia Roig García, Miguel Torres Valero, Roberto Reig Piqueres, Raúl Ferrando Campos, Lidón Mateu Rincón, José Manuel Ramos Blasco, Jorge Usó Nirmatrelvir/ritonavir as a possible treatment for Long-COVID |
| title | Nirmatrelvir/ritonavir as a possible treatment for Long-COVID |
| title_full | Nirmatrelvir/ritonavir as a possible treatment for Long-COVID |
| title_fullStr | Nirmatrelvir/ritonavir as a possible treatment for Long-COVID |
| title_full_unstemmed | Nirmatrelvir/ritonavir as a possible treatment for Long-COVID |
| title_short | Nirmatrelvir/ritonavir as a possible treatment for Long-COVID |
| title_sort | nirmatrelvir/ritonavir as a possible treatment for long-covid |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586732/ https://www.ncbi.nlm.nih.gov/pubmed/37357766 http://dx.doi.org/10.37201/req/028.2023 |
| work_keys_str_mv | AT catalanignacioperez nirmatrelvirritonavirasapossibletreatmentforlongcovid AT bujadrianagascon nirmatrelvirritonavirasapossibletreatmentforlongcovid AT munozsergiogarcia nirmatrelvirritonavirasapossibletreatmentforlongcovid AT alfaroirisgomez nirmatrelvirritonavirasapossibletreatmentforlongcovid AT marticeliaroig nirmatrelvirritonavirasapossibletreatmentforlongcovid AT garciamigueltorres nirmatrelvirritonavirasapossibletreatmentforlongcovid AT valerorobertoreig nirmatrelvirritonavirasapossibletreatmentforlongcovid AT piqueresraulferrando nirmatrelvirritonavirasapossibletreatmentforlongcovid AT camposlidonmateu nirmatrelvirritonavirasapossibletreatmentforlongcovid AT rinconjosemanuelramos nirmatrelvirritonavirasapossibletreatmentforlongcovid AT blascojorgeuso nirmatrelvirritonavirasapossibletreatmentforlongcovid |